30家国际知名医疗企业半年财报一览

admin

                    

                    

                    
                    
                    <section data-role="paragraph" data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section><p><p><img src="image/20201014/86b79d371e9862b01189f0252a03b2cd_1.png" /></p></p></section><section><section><span><strong></strong></span></section><p><span>医疗器械媒体报道先锋</span></p><p><span>分享专业医疗器械知识</span></p></section><section><section><section><span>关注</span></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><p><br  /></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="86134" data-color="#27939d"><section><section><span><strong><span data-original-title="" title="">1</span></strong></span></section><section><section data-width="20%"></section></section><p><span><strong><span data-brushtype="text">医疗设备</span></strong></span><strong><span data-brushtype="text"></span></strong></p></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><p><span>声明：文章内各排名不分先后。</span><span></span><br  /></p><p><span><br  /></span></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">GPS</section></section><section><section><section data-autoskip="1"><p><span>我们首先来看医械界三驾马车“GPS”的表现。2019上半年，三家医疗领域规模排名为GE第一，西门子第二，飞利浦第三。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">GE</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/cdf2454fece0443de39000cf57383a22_2.png" /></p></p><p><br  /></p><p><span>具体来看，GE稳坐龙头地位，2019年Q1季度同比持平，Q2季度营收49.34亿美元，占集团总营收的17.13%，同比下降1%，是三家中唯一出现负增长的企业，不过得益于其成本控制和架构重组（通货膨胀、医疗保健系统的价格压力、数字和医疗保健系统新产品引入等），GE医疗的利润同比上涨+5%。</span><span></span></p><p><br  /></p><p><span>另外，近日GE深陷财报造假丑闻，虽然GE立即做出回应，予以明确否认，但股价仍然大受波及，为下半年的财务状况留下了一个不确定的X因素。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">西门子</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/996e17ae83b51e432fc200f01af740e5_3.gif" /></p></p><p><span>西门子医疗(Siemens Healthineers)公布2019财年第三季度(4月1日-6月30日)财报。当季营收35.69亿欧元(约39.6亿美元)，上年同期为33.00亿欧元。当季净利润3.53亿欧元，上年同期为2.93亿欧元。</span></p><p><br  /></p><p><span>西门子医疗上半年营收表现良好，同比增长6%，影像业务是其增长的主要驱动力。中国市场上，则是由诊断和临场治疗业务驱动增长。净利润大幅提升（+17%）。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">飞利浦</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/dab8474fda73c548d1f24e27e290055e_4.gif" /></p></p><p><br  /></p><p><span>飞利浦(Philips)公布2019年第二季度业绩。当季销售额46.71亿欧元(约51.8亿美元)，上年同期为42.88亿欧元。当季净利润2.46亿欧元，上年同期为200万欧元。当季调整后的EBITDA利润为7.76亿欧元，上年同期为6.61亿欧元。</span></p><p><span><br  /></span></p><p><br  /></p><p><span>同时，飞利浦以8%的增长率，拿下2019上半年GPS营收增速之首。相较于其他两家，飞利浦的净利润一直偏低，但2019上半年，飞利浦净利润增加2.83亿欧元达4.09亿欧元，暴涨+225%！</span><span></span></p><p><br  /></p><p><p><img src="image/20201014/94844915ec1234fc73079c3d1464c09a_5.png" /></p></p><p><span>图片来源MedTrend医趋势</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><p><span>看过GPS，我们再来关注一下其他国际医械大品牌上半年的表现。</span></p><p><br  /></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>强生</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/1fc6352b93144e786e047839784d2b14_6.gif" /></p></p><p><br  /></p><p><span>2019年Q2季度，强生集团(Johnson &amp; Johnson)整体营收205.62亿美元，同比下降1.3％。，其中美国销售额104亿美元。医疗设备业务Q2季度总营收64.89亿美元，按报告同比下跌6.9%；消费者业务总营收35.44亿元，按报告同比增长1.2%；制药业务：2019年Q2季度，总营收105.29亿元，按报告同比增长1.7%。</span><span></span></p><p><br  /></p><p><p><img src="image/20201014/8c22e005e5f01c0633cc1b2a79d1a577_7.png" /></p></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>美敦力</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/78a938a10da9501ff3bcad7d3b738b08_8.gif" /></p></p><p><br  /></p><p><span>美敦力(Medtronic plc)发布2020财年第一季度（2019年4月27日—2019年7月26日）业绩，营收和净利润均超预期实现强劲增长。当季总营收74.93亿欧元(约83.1亿美元)，上年同期为73.84亿欧元，按报告同比增长1.5％，按固定汇率计算增长3.5％。当季营业利润14.85亿欧元，上年同期为12.36亿欧元。当季净利润8.64亿欧元，上年同期为10.75亿欧元，按报告同比增长6％。</span><span></span></p><p><br  /></p><p><p><img src="image/20201014/61fad2697f090357d7f874bf882f05c3_9.jpg" /></p></p><p><span>图片来源医疗器械经销商联盟</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">雅培</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/560e73fe2a5b1dbbc2b84d3aa08fdab6_10.gif" /></p></p><p><br  /></p><p><span>雅培(Abbott)公布二季度业绩。当季营收79.79亿美元，比上年同期增长2.7%，有机增长7.5%，<span>每股收益上涨13%，调整后的稀释每股收益为0.82美元，超过华尔街预期。</span>其中，医疗设备业务营收30.75亿美元，<span>同比增长10.5%</span>；诊断业务营收19.05亿美元，同比增长<span>6.2</span>%。营养业务营收18.75亿美元，同比增长<span>5.1%</span>；制药业务营收11.08亿美元，同比增长<span>6.1%</span>。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"></section><p><br  /></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">佳能</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/7fbc858242863043d86c2982f6843f51_11.jpg" /></p></p><p><br  /></p><p><span>佳能集团发布2019年第二季度财报。据财报显示，2019年第二季度佳能集团营业额同比降低10%，为9,058.69亿日元。其中，医疗领域稳步扩大，销售额对比去年同期增长11%。</span></p><p><br  /></p><p><span>医疗系统业务领域，CT设备新品Aquilion Start与Aquilion Genesis等销售持续上涨，同时日本国内设备投资回暖，使得以X射线诊断设备为首的各产品系列销售均有大幅提升。因此，该领域本季度营业额同比增长迅速，涨幅达11.0%，达到1,051亿日元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">瓦里安</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/0b6f7a86877622566617e5fb517e1cf6_12.jpg" /></p></p><p><br  /></p><p>8月7日瓦里安医疗(股票代码：VAR)公布财报，<span>营业收入为23.46亿美元，</span>公告显示公司2019财年三季报(累计)归属于普通股东净利润为2.22亿美元。</p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section></section></section></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>费森尤斯</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/f23a6c5df4c1afe063ce2c0286390a33_13.gif" /></p></p><p><br  /></p><p><span>透析设备巨头费森尤斯集团(Fresenius SE &amp; Co. KGaA)公布2019年第二季度业绩。当季销售额87.61亿欧元(约97.2亿美元)，上年同期为83.82亿欧元。当季营业利润11.18亿欧元，上年同期为19.43亿欧元。当季净利润4.80亿欧元，上年同期为4.73亿欧元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">丹纳赫</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/af248e759a41445ffc8896f4b2a45e92_14.gif" /></p></p><p><span>丹纳赫(Danaher)公布2019年第二季度业绩。当季销售额51.57亿美元，上年同期为49.81亿美元。当季净利润7.09亿美元，上年同期为6.74亿美元。</span></p><p><br  /></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">BD</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/b9355bcb347a15607049523ad5345f73_15.gif" /></p></p><p><br  /></p><p><span>碧迪(Becton, Dickinson and Company)公布2019财年第三财季(截至6月30日)业绩。当季营收43.50亿美元，上年同期为42.78亿美元。当季净利润4.13亿美元，上年同期为5.56亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text">奥林巴斯</section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/097bc44316868373140ca198f898d954_16.jpg" /></p></p><p><br  /></p><p><span>奥林巴斯公布本财年第一季财报。由于内部重组导致新品迟迟无法上市以及日益严峻的市场情势，影像业务的营收录得同比下跌 27%，营利仍然处于亏损中，但幅度在缩小。奥巴对全年的营收预期仍然积极，不过全年营利预期已调整为亏损。</span></p><p><span><br  /></span></p><p><p><img src="image/20201014/e2fdbecca860be79118878fe1dd1d687_17.jpg" /></p></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>史赛克</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/fdf9774456f2f056d4eceb4d4a0e2796_18.gif" /></p></p><p><span>医疗设备制造商史赛克(Stryker)公布2019年第二季度业绩。当季净销售额36.50亿美元，上年同期为33.22亿美元。当季营业利润6.13亿美元，上年同期为7.72亿美元。当季净利润4.80亿美元，上年同期为4.52亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>百特国际</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/dd8e8d07f9a1fca38b723b36447883ed_19.gif" /></p></p><p><span>百特国际(Baxter International Inc)公布2019年第二季度业绩。当季净销售额28.40亿美元，上年同期为28.42亿美元。当季营业利润3.55亿美元，上年同期为3.84亿美元。当季净利润3.43亿美元，与上年同期持平。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>波士顿科学</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/a9399905085c29c5da5c9dc0e6065096_20.gif" /></p></p><p><span>波士顿科学(Boston Scientific)公布2019年第二季度业绩。当季净销售额26.31亿美元，上年同期为24.90亿美元。当季营业利润3.84亿美元，上年同期为3.92亿美元。当季净利润1.54亿美元，上年同期为5.55亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>捷迈邦美</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/46418387808ee95c90b9e8865dee6d0f_21.gif" /></p></p><p><span>捷迈邦美(Zimmer Biomet Holdings Inc)公布2019年第二季度业绩。当季净销售额19.89亿美元，上年同期为20.08亿美元。当季营业利润2.05亿美元，上年同期为2.96亿美元。当季净利润1.34亿美元，上年同期为1.85亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>爱尔康</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/42f3857cea3ff68017579f382664c180_22.jpg" /></p></p><p><span>爱尔康(Alcon)公布第二季度和上半年业绩。第二季度销售额营收19.03亿美元，上年同期为18.20亿美元。第二季度净亏损3.90亿美元，上年同期净利润1500万美元。上半年净销售额37.27亿美元，上年同期为36.00亿美元。上半年净亏损4.99亿美元，上年同期净利润5300万美元。</span></p></section></section><section></section><section></section></section></section></section></section><p><br  /></p><p><span></span></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>实验美控</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/b39ced6ee0835fdaf9ca6c75ce328e87_23.gif" /></p></p><p><span>实验美控(LabCorp)公布2019年第二季度业绩。当季营收28.82亿美元，上年同期为28.66亿美元。当季营业利润3.36亿美元，上年同期为3.69亿美元。当季净利润1.90亿美元，上年同期为2.34亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>奎斯特诊疗</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/3d07a48a9f8871bc19ad507768ace7bb_24.gif" /></p></p><p><span>奎斯特诊疗(Quest Diagnostic)公布2019年第二季度业绩。当季净营收19.53亿美元，上年同期为19.19亿美元。当季营业利润3.07亿美元，上年同期为3.05亿美元。当季净利润2.06亿美元，上年同期为2.19亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-tools="gulangu" data-id="86134" data-color="#27939d"><section><section><span><strong><span data-original-title="" title="">2</span></strong></span></section><section><section data-width="20%"></section></section><p><strong><span data-brushtype="text">药品批发零售、医疗机构</span></strong></p></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>麦克森</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/878fa4e80863f2b81f89386be7535264_25.gif" /></p></p><p><span>医疗供应链管理公司麦克森(McKesson)公布2020财年第一季度业绩(截至6月30日)。当季营收557.28亿美元，上年同期为526.07亿美元。当季净利润4.23亿美元，上年同期净亏损1.38亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>嘉德诺</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/eaa154385071d44220cec6c90cd1eed5_26.gif" /></p></p><p><span>嘉德诺(Cardinal Health)公布2019财年第四季度和全年业绩。第四财季营收373.53亿美元，上年同期为353.49亿美元。当季净利润1.94亿美元，上年同期净亏损11.66亿美元。财年营收1455.34亿美元，上年为1368.09亿美元。全财年净利润13.63亿美元，上年净利润2.56亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>CVS Health&nbsp;Corp</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/4fc2224ebfd8c06c8ab5a75a4a068213_27.gif" /></p></p><p><span>药品零售商CVS Health Corp公布2019年第二季度业绩。当季总营收634亿美元，上年同期为469亿美元。当季净利润19.31亿美元，上年同期净亏损25.63亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>沃博联</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/6fd7064a3da2c259d4c0ac46a5fe2b4b_28.gif" /></p></p><p><span>连锁药店巨头沃博联(Walgreens Boots Alliance, Inc. )公布截至5月31日的2019财年第三财季业绩。当季销售额345.9亿美元，上年同期为343.34亿美元。当季净利润10.25亿美元，上年同期为13.42亿美元。利润下降的主要原因是药房利润率下滑，英国药店业务疲软。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>HCA Healthcare Inc</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/9ed5c357e5da962c285053892226cc94_29.gif" /></p></p><p><span><br  /></span></p><p><span>医院运营商HCA Healthcare Inc公布2019年第二季度业绩。当季总营收126亿美元，上年同期为115亿美元。当季净利润7.83亿美元，上年同期为8.20亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>Tenet Healthcare Corporation</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/57219a9ebec6b9d01dde898d67525791_30.gif" /></p></p><p><span>医院运营商Tenet Healthcare Corporation公布2019年第二季度业绩。当季营收45.60亿美元，上年同期为45.06亿美元。当季净利润1700万美元，上年同期为2600万美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-tools="gulangu" data-id="86134" data-color="#27939d"><section><section><span><strong><span data-original-title="" title="">3</span></strong></span></section><section><section data-width="20%"></section></section><p><strong><span data-brushtype="text">医疗保险</span></strong></p><p><br  /></p></section></section><section data-role="paragraph" data-color="#27939d"></section><p><br  /></p><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>联合健康集团</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/8611f3dd67d3f62ada30afbaea0d1d43_31.gif" /></p></p><p><span>联合健康集团(UnitedHealth Group)公布2019年第二季度业绩。当季总营收605.95亿美元，上年同期为560.86亿美元。当季净利润32.93亿美元，上年同期为29.22亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>信诺</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/f995e9a96be7946f92dcbee49d7f3996_32.gif" /></p></p><p><span>信诺(Cigna Corporation)公布2019年第二季度业绩。当季总营收388.19亿美元，当季净利润14.08亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>Anthem, Inc</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/b1d03a1b2490a8e0db1663878a3bdd98_33.gif" /></p></p><p><span>Anthem, Inc.公布2019年第二季度业绩。当季总营收254.66亿美元，上年同期为229.44亿美元。当季净利润11.39亿美元，上年同期为10.54亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>康西哥</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/f8d5de0126609cc871386b866c9a0936_34.gif" /></p></p><p><span>康西哥(Centene Corporation)公布2019年第二季度业绩。当季总营收183.56亿美元，上年同期为141.81亿美元。当季净利润4.95亿美元，上年同期为3.00亿美元。</span></p></section></section><section></section><section></section></section></section></section><section data-role="paragraph" data-color="#27939d"><p><br  /></p></section></section><section data-role="outer" label="Powered by gulangu"><section data-tools="gulangu" data-id="94817" data-color="#27939d"><section data-width="100%"><section><section data-brushtype="text"><span>哈门那</span></section></section><section><section><section data-autoskip="1"><p><p><img src="image/20201014/fe51e7f8db4f5d77c3ea3d27c5562844_35.gif" /></p></p><p><span>医保公司哈门那(Humana Inc)公布2019年第二季度业绩。当季总营收162.45亿美元，上年同期为142.59亿美元。当季净利润9.40亿美元，上年同期为1.93亿美元。</span></p></section></section><section></section><section></section></section></section></section></section></section><p><br  /></p><section><a data-miniprogram-appid="wxdc7efe409d688f37" data-miniprogram-path="pages/authorizationLogin/authorizationLogin" data-miniprogram-nickname="" href="" data-miniprogram-type="image" data-miniprogram-servicetype="" href=""><p><img src="image/20201014/2e25c809fffd6ef0866d70b58effc1a6_36.gif" /></p></a><br  /></section><section><br  /></section><section powered-by="gulangu"><section powered-by="gulangu"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph"><section><section><section data-brushtype="text"><strong>相关阅读</strong></section></section></section><section><section></section></section><section data-width="100%"><section><section><section><section data-width="100%"><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><section><p><img src="image/20201014/2aac877ff9233ba5a66e7a5ff3a4febf_37.gif" /></p></section><section data-brushtype="text">戳一下，更有料！</section></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><p><span>重磅!2018全球医疗器械企业财报出来了！</span><br  /></p><p><br  /></p><p><span>21家IVD上市公司发布2018年业绩预告，19家企业大丰收！</span><br  /></p></section></section></section></section></section></section></section></section></section><p><br  /></p><p><p><img src="image/20201014/cd6e6da350853c459044672a7cf353fb_38.jpg" /></p></p>